They Need to Be Seen! Domestic Innovation "Anti-HIV Twin Stars" Protect the Health of Women Living with HIV

96-Week SPRINT Study of China’s Innovative Antiretroviral Ainuomiti Tablets Featured at CROI 2025

Key Events in 2024

Immediate Switch! Phase III SPRINT Study of Aitribond® Has Been Published in the Top International Journal The Lancet Regional Health–Western Pacific

New Indication Application of Aitribond® Was Approved

Chairman Heliang Fu led delegation to visit Namibia, and received warm welcome from President Mbumba

Real benefits! Five Real-World Studies Demonstrated Multiple Benefits in Blood Lipids and Nervous System Safety from Ainuovirine-based Regimens

The Voice of China! Aidea Pharma’s Innovative Drug to be Presented at AIDS 2024

The Light of Asia-Pacific! Aidea Pharma’s Three Clinical Studies to be Presented at APACC 2024